Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Saturday, January 31, 2015
The White House 2016 Budget Includes Big Funding for Antibiotic Resistance BY MARYN MCKENNA 01.31.15 | 8:40 AM
'Right to Try' bill would give access to experimental drugs
'Right to Try' bill would give access to experimental drugs
It can be years before drugs leave the clinical-trial phase and get approval by the FDA. Connelly said the 2014 movie "Dallas Buyers Club," based on an AIDS ...
Lab-developed tests don't need new layer of oversight, and other
Lab-developed tests don't need new layer of oversight, and other ...
(“Why the FDA should regulate lab tests,”) That is a good thing. The average person should come to understand how something that may seem of remote ...
Billerica pharmacy to pay $1.5M for Medicaid billing errors The Lowell Sun
The Lowell Sun
UPDATED: 01/31/2015 06:34:36 AM EST0 COMMENTS
BOSTON -- A Billerica pharmacy has agreed to pay more than $1.5 million to settle allegations it improperly billed and received payments from the state's Medicaid program when it automatically refilled prescription medications that were not requested by MassHealth patients or caregivers.
Neighborhood Diabetes, Inc., listed at 600 Technology Park Drive, unit 201, will pay more than $1.5 million in restitution to the state for the overpayments, and be subject to additional reporting requirements to ensure compliance in the future.
Read more: http://www.lowellsun.com/news/ci_27432073/billerica-pharmacy-pay-1-5m-medicaid-billing-errors#ixzz3QS6xynTr
January 26, 2015 FTC Proposes Amendments to Fair Packaging and Labeling Act Rules
If your company sells consumer products, you’ll want to take a look at the Federal Trade Commission’s (FTC’s) proposed amendments to its Fair Packaging and Labeling Act (FPLA)rules announced on January 22, 2015. The most significant proposed change is eliminating the rules on certain price representations -- the cents off, introductory offer, andeconomy size rules -- because they are no longer common in the marketplace and the Commission has other means for policing deceptive price representations. more
Fourth Question of the Day January 31, 2015 How many false and misleading claims by compounding pharmacies will we see the Federal Trade Commission Take on this year? How many compounding pharmacy websites need to clean up and remove these type of claims from their websites? Are the organizations that represent these groups advocating for compliance in this area or will they oppose any regulation by the FTC?
Subscribe to:
Posts (Atom)